U.S. markets open in 8 hours 4 minutes
  • S&P Futures

    3,929.50
    +7.00 (+0.18%)
     
  • Dow Futures

    31,998.00
    +82.00 (+0.26%)
     
  • Nasdaq Futures

    13,330.50
    +28.50 (+0.21%)
     
  • Russell 2000 Futures

    2,298.70
    +13.60 (+0.60%)
     
  • Crude Oil

    63.34
    +0.12 (+0.19%)
     
  • Gold

    1,794.20
    -3.70 (-0.21%)
     
  • Silver

    28.01
    +0.16 (+0.56%)
     
  • EUR/USD

    1.2180
    +0.0012 (+0.10%)
     
  • 10-Yr Bond

    1.3890
    0.0000 (0.00%)
     
  • Vix

    21.34
    -1.77 (-7.66%)
     
  • GBP/USD

    1.4159
    +0.0018 (+0.13%)
     
  • USD/JPY

    105.9270
    +0.0450 (+0.04%)
     
  • BTC-USD

    50,485.24
    +164.93 (+0.33%)
     
  • CMC Crypto 200

    1,007.92
    +13.26 (+1.33%)
     
  • FTSE 100

    6,658.97
    +33.03 (+0.50%)
     
  • Nikkei 225

    30,168.27
    +496.57 (+1.67%)
     

Zai Lab Announces Upcoming Participation at February Conferences

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

SHANGHAI, China and SAN FRANCISCO, Feb. 11, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) (ZLAB), a China and U.S.-based innovative commercial-stage biopharmaceutical company, today announced that Dr. Samantha Du, Founder and Chief Executive Officer, will be presenting at the following upcoming conferences in February. Details of the conferences are as follows:

Guggenheim Healthcare Talks | Idea Forum | Oncology Day
Presentation: Thursday, February 13, 2020 at 3.30 p.m. ET
Presenter: Dr. Samantha Du, Founder & Chief Executive Officer
Location: St. Regis Hotel, New York, NY

SVB Leerink Global Healthcare Conference
Presentation: Tuesday, February 25, 2020 at 10:30 a.m. ET
Presenter: Dr. Samantha Du, Founder & Chief Executive Officer
Location: Lotte New York Palace, New York, NY

Live webcasts of the conferences will be available under "Events & Presentations” in the “Investors Relations” section of Zai Lab’s website. Archived replays will be available for 90 days following the event.

About Zai Lab
Zai Lab (ZLAB) is a China and U.S.-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide.

For more information, please contact:

ZAI LAB CONTACTS:

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media: Ryo Imai / Robert Flamm, Ph.D.
Burns McClellan, on behalf of Zai Lab
212-213-0006 ext. 315 / 364
rimai@burnsmc.com / rflamm@burnsmc.com

Investors: Pete Rahmer / Mike Zanoni
Endurance Advisors, on behalf of Zai Lab
415-515-9763 / 610-442-8570
prahmer@enduranceadvisors.com / mzanoni@enduranceadvisors.com